SLC5A5 and cancer: Expression of NIS is cancer cells allows for the therapeutic application of radioactive substrates of NIS, such as 123I, 124I, and 127I. It is suggested that NIS expressed in thyroid primary tumors may be helpful in anticancer therapy [110,111].